Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Mitsudomi

Showing results (121-130 of 336) with videos related to

Pageof 34
Sort By:
Biomed Research International|November 6, 2014
Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinomaKenichi Suda, Katsuaki Sato, Shigeki Shimizu, et al.
Lung Cancer (Amsterdam, Netherlands)|October 6, 2012
Impact of age on epidermal growth factor receptor mutation in lung cancerTsuyoshi Ueno, Shinichi Toyooka, Kenichi Suda, et al.
Biomolecules|September 11, 2019
Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung AdenocarcinomasKenichi Suda, Masaki Shimoji, Shigeki Shimizu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinibTakayuki Kosaka, Yasushi Yatabe, Hideki Endoh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2011
Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinibKenichi Suda, Kenji Tomizawa, Makiko Fujii, et al.
Surgical Case Reports|February 28, 2024
A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulationRie Shimizu, Kenichi Suda, Toshiki Takemoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2009
[Feasibility and response of gemcitabine and carboplatin biweekly combination chemotherapy for patients with postoperative recurrence non-small cell lung cancer]Syoichi Mori, Rei Kobayashi, Katsuhiro Okuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reactionHideki Endoh, Shuta Tomida, Yasushi Yatabe, et al.
Biomedicines|July 27, 2024
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro StudyShota Fukuda, Kenichi Suda, Akira Hamada, et al.
Clinical Lung Cancer|November 9, 2021
Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung CancerKenichi Suda, Shuta Ohara, Toshio Fujino, et al.
Pageof 34

Showing results (121-130 of 336) with videos related to

Sort By:
Pageof 34
Biomed Research International|November 6, 2014
Prognostic implication of predominant histologic subtypes of lymph node metastases in surgically resected lung adenocarcinomaKenichi Suda, Katsuaki Sato, Shigeki Shimizu, et al.
Lung Cancer (Amsterdam, Netherlands)|October 6, 2012
Impact of age on epidermal growth factor receptor mutation in lung cancerTsuyoshi Ueno, Shinichi Toyooka, Kenichi Suda, et al.
Biomolecules|September 11, 2019
Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung AdenocarcinomasKenichi Suda, Masaki Shimoji, Shigeki Shimizu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinibTakayuki Kosaka, Yasushi Yatabe, Hideki Endoh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 21, 2011
Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinibKenichi Suda, Kenji Tomizawa, Makiko Fujii, et al.
Surgical Case Reports|February 28, 2024
A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulationRie Shimizu, Kenichi Suda, Toshiki Takemoto, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 20, 2009
[Feasibility and response of gemcitabine and carboplatin biweekly combination chemotherapy for patients with postoperative recurrence non-small cell lung cancer]Syoichi Mori, Rei Kobayashi, Katsuhiro Okuda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2004
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reactionHideki Endoh, Shuta Tomida, Yasushi Yatabe, et al.
Biomedicines|July 27, 2024
Potential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms-An In Vitro StudyShota Fukuda, Kenichi Suda, Akira Hamada, et al.
Clinical Lung Cancer|November 9, 2021
Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung CancerKenichi Suda, Shuta Ohara, Toshio Fujino, et al.
Pageof 34